Arbli From Scienture
FDA approves a new liquid formulation of losartan for hypertension treatment, enhancing accessibility for adults and children over 6 years…
Pharmacists and Providers: Key Collaborators in the Shift Toward Decentralized and Virtual Health Care
Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.
New Drug Combination Shows Promise Against Resistant Influenza Strains
Researchers unveil a promising drug combination, arainosine and theobromine, that effectively targets influenza A M2 channels, outperforming existing treatments.
Semaglutide Receives FDA Approval for Treatment of MASH
FDA approves semaglutide for treating MASH, offering new hope for affected individuals.
Kennedy’s mRNA cuts could set US science back, experts warn
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it…
Adapting Oncology Pharmacy to the Age of AI and Drug Shortages
Oncology pharmacists are increasingly shaping patient care.
Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
Patient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data – 09/18/2025
On September 18 and 19, 2025, the U.S. Food and Drug Administration (FDA) is hosting a virtual public workshop to…
Telehealth’s Next Chapter – Healthcare IT Today Podcast Episode 173
For the 173rd episode of the Healthcare IT Today Podcast, I am joined by special guest host Brian Eastwood to…